Svetlana Miroshnichenko

6PUBLICATIONS
21CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Biomolecular modelling and design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 26, 2026
Panel-Wide Screening of Tumour Cells of Diverse Histogenesis for Responsiveness to Silencing of miR-21, miR-17, and miR-155 by Mesyl Phosphoramidate Antisense Oligonucleotides.

|Jan 28, 2026
Targeted Inhibition of Oncogenic microRNAs miR-21, miR-17, and miR-155 Suppresses Tumor Growth and Modulates Immune Response in Colorectal Cancer.

Olga Patutina, Aleksandra Sen'kova, Svetlana Miroshnichenko

|Dec 30, 2025
Reversing the Irreversible: miRNA-Targeting Mesyl Phosphoramidate Oligonucleotides Restore Sensitivity to Cisplatin and Doxorubicin of KB-8-5 Epidermoid Carcinoma Cells.

Svetlana Miroshnichenko, Rabia Demirel, Arseny Moralev

|Dec 11, 2025
Biological Performance and Molecular Mechanisms of Mesyl MicroRNA-Targeted Oligonucleotides in Colorectal Cancer Cells.

Svetlana K Miroshnichenko, Olga A Patutina, Andrey V Markov

|Sep 23, 2022
Single Shot vs. Cocktail: A Comparison of Mono- and Combinative Application of miRNA-Targeted Mesyl Oligonucleotides for Efficient Antitumor Therapy.

Svetlana Gaponova, Olga Patutina, Aleksandra Sen'kova

|Jun 24, 2022
Bulge-Forming miRNases Cleave Oncogenic miRNAs at the Central Loop Region in a Sequence-Specific Manner.

Olga Patutina, Daria Chiglintseva, Bahareh Amirloo

Pageof 1

Frequent Collaborators

6 joint publications

Marina Zenkova

4 joint publications

Mikhail Maslov

3 joint publications

Andrey V Markov

3 joint publications

Dmitry Stetsenko